These findings support the concept that sustained elevations in PTH, even in the absence of overt hypercalcemia, may promote bone loss through mechanisms compatible with SHPT, commonly triggered by chronic VitD insufficiency (Figure 6). This evidence concerns the gene PTH and Hypercalcemia.